Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Structure Therapeutics, Inc.

Latest From Structure Therapeutics, Inc.

IPOs Fizzle Out In The Fourth Quarter

Just three biotech companies floated in the last three months of 2023, but there may be hope for a resurgence next year.

Financing Business Strategies

Structure’s Oral Weight Loss Drug Data Underperforms A Big Rival

The company is advancing a Phase II candidate in the closely watched and competitive category of oral GLP-1 receptor agonists for diabetes and weight loss.

Metabolic Disorders Clinical Trials

Time For Oral Incretins To Prove Their Worth

Several crucial trial readouts in diabetes and obesity will come this year and next, and the stakes are high.

Clinical Trials Metabolic Disorders

Finance Watch: Adlai Nortye Raises $97.5m In IPO, Brings US Total To 18

Public Company Edition: Cancer-focused Adlai Nortye launched a concurrent initial public offering and private placement, while four other drug developers announced or completed SPAC mergers. Also, Sobi grossed $540m in a rights issue and Immunovant followed early data with a $450m FOPO.

Financing Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Technologies
      • ADMET
      • Bioinformatics
  • Other Names / Subsidiaries
    • Basecamp Bio
    • Shanghai ShouTi Biotechnology Co. Ltd.
    • ShouTi, Inc.